Audiovisual Librairy of the European CommissionEU CommissionEU bioeconomy strategy enters crucial phas...Europe’s decision on how to combine economic growth and decarbonisation in the future depends on the renewal of the EU bioeconomy strategy. The question is whether the EU will fall further behind globally … more ➔
market.usRegulatoryEMA set to simplify biosimilar approvalThe EMA has asked the industry to share their thoughts on its draft guidelines for developing and assessing biosimilars. The idea is to make it easier for patients in the EU to get access to biosimilars, … more ➔
Acoustofab LtdSLASSLAS selects 12 most innovative automation...The Society for Laboratory Automation and Screening (SLAS) has selected 12 start-ups to exhibit at Europe’s premier automation conference as part of its Innovation AveNew programme at SLAS Europe 2025, … more ➔
Lee Haines, photographerMalariaNew drug kills mosquitos by blood poisonin...A drug named nitisinone, EU-approved for the treatment of metabolic diseases, also shows strong mosquito-killing properties. According to researchers headed by Lee Haines, it turns human blood toxic … more ➔
MPI for Biochemistry - AusserhoferMolecular BiologyResearchers crack the code of protein degr...Researchers at the Max Planck Institute of Biochemistry (MPIB) and MRC Laboratory of Molecular Biology in Cambridge have developed and patented the new UbiREAD technology, which decodes the complex … more ➔
pleiotrope - wikipedia.orgFinancingAugustine Therapeutics NV raises €78m in...Leuven-based Augustine Therapeutics NV will use the proceeds from a €77.7m in Series A financing led by Novo Holdings and Jeito Capital to advance its preclinical HDAC6 inhibitor AGT-100216 for the … more ➔
Adobe Stock photos - ARTMAXX Deep-tech bioeconomyUK to boost scale-up of biomanufacturing i...The House of Lords Science and Technology Committee wants to improve technology transfer in industrial biotechnology through better regulation, more funding, and improved access to scale-up infrastructure … more ➔
Dren Bio IncLicence dealSanofi to acquire Dren Bio’s bispecific...French Sanofi SA announced that it will acquire Dren Bio Inc’s bispecific myeloid cell engager DR-0201 for upfront US$600m and US$1.3bn in milestones. The deal is expected to close in Q2/2025. more ➔
Brainomix Ltd.FinancingBrainomix Ltd. completes £14m Series C fi...University of Oxford spinout Brainomix Ltd has closed a £14m Series C round to advance its commercial expansion in the US. Funding will also support clinical uptake of its AI imaging technology in stroke … more ➔
EvonikEconomic growthUS President deprioritises biotechnologyThe U.S. administration of President Donald Trump has revoked Executive Order 14081, “Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe, and Secure American Bioeconomy,” … more ➔